AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Depreciation & amortization

Chiome Bioscience Inc.【JP:4583】

Market cap
¥7.4B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDepreciation & amortization (Million JPY)YoY (%)
Dec 31, 20254+220.75%
Dec 31, 20241-3.08%
Dec 31, 20231-18.50%
Dec 31, 20221-50.07%
Dec 31, 20213-20.19%
Dec 31, 20204-23.52%
Dec 31, 20195-30.97%
Dec 31, 20187-33.77%
Dec 31, 201711-90.63%
Dec 31, 2016113+10.49%
Dec 31, 2015102

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)